DK2721152T3 - Dimere bindingsproteiner baseret på modificerede ubiquitiner - Google Patents
Dimere bindingsproteiner baseret på modificerede ubiquitiner Download PDFInfo
- Publication number
- DK2721152T3 DK2721152T3 DK12729509.5T DK12729509T DK2721152T3 DK 2721152 T3 DK2721152 T3 DK 2721152T3 DK 12729509 T DK12729509 T DK 12729509T DK 2721152 T3 DK2721152 T3 DK 2721152T3
- Authority
- DK
- Denmark
- Prior art keywords
- ubiquitines
- dimere
- modified
- binding proteins
- proteins based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11170054 | 2011-06-15 | ||
PCT/EP2012/061455 WO2012172055A1 (en) | 2011-06-15 | 2012-06-15 | Dimeric binding proteins based on modified ubiquitins |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2721152T3 true DK2721152T3 (da) | 2019-07-01 |
Family
ID=44680786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12729509.5T DK2721152T3 (da) | 2011-06-15 | 2012-06-15 | Dimere bindingsproteiner baseret på modificerede ubiquitiner |
Country Status (8)
Country | Link |
---|---|
US (1) | US9492572B2 (da) |
EP (1) | EP2721152B1 (da) |
JP (1) | JP6146821B2 (da) |
AU (1) | AU2012268970B2 (da) |
CA (1) | CA2837804C (da) |
DK (1) | DK2721152T3 (da) |
IL (1) | IL229722A (da) |
WO (1) | WO2012172055A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4088742B2 (ja) | 2000-12-26 | 2008-05-21 | 信越化学工業株式会社 | フォトマスクブランクス、フォトマスク及びフォトマスクブランクスの製造方法 |
JP2002244274A (ja) | 2001-02-13 | 2002-08-30 | Shin Etsu Chem Co Ltd | フォトマスクブランク、フォトマスク及びこれらの製造方法 |
EP2428563A1 (en) * | 2005-02-10 | 2012-03-14 | Regents Of The University Of Minnesota | Vascular/lymphatic endothelial cells |
EP3253795B1 (en) | 2015-02-06 | 2019-04-17 | Navigo Proteins Gmbh | Novel binding proteins comprising a ubiquitin mutein and antibodies or antibody fragments |
DK3253785T3 (da) | 2015-02-06 | 2019-07-08 | Navigo Proteins Gmbh | Hidtil ukendte egfr-bindingsproteiner |
DK3322721T3 (da) | 2015-07-16 | 2022-03-14 | Navigo Proteins Gmbh | Nye immunglobulin-bindende proteiner og deres anvendelse i affinitetsoprensning |
WO2017013136A1 (en) * | 2015-07-20 | 2017-01-26 | Scil Proteins Gmbh | Novel binding proteins based on di-ubiquitin muteins and methods for generation |
CA3022751A1 (en) | 2016-05-04 | 2017-11-09 | Navigo Proteins Gmbh | Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linker |
AU2017311542B2 (en) | 2016-08-11 | 2021-06-24 | Repligen Corporation | Alkaline stable Fc—binding proteins for affinity chromatography |
WO2019091918A1 (en) | 2017-11-07 | 2019-05-16 | Navigo Proteins Gmbh | Fusion proteins with specificity for ed-b and long serum half-life for diagnosis or treatment of cancer |
US20230416345A1 (en) * | 2020-11-09 | 2023-12-28 | Navigo Proteins Gmbh | New type ii collagen binding proteins |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873192A (en) | 1987-02-17 | 1989-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Process for site specific mutagenesis without phenotypic selection |
SE9103701D0 (sv) | 1991-12-13 | 1991-12-13 | Kabi Pharmacia Ab | Apolipoprotein |
US5958684A (en) | 1995-10-02 | 1999-09-28 | Van Leeuwen; Frederik Willem | Diagnosis of neurodegenerative disease |
US6217863B1 (en) | 1995-10-30 | 2001-04-17 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from heparinase I |
US5789166A (en) | 1995-12-08 | 1998-08-04 | Stratagene | Circular site-directed mutagenesis |
GB9610967D0 (en) | 1996-05-24 | 1996-07-31 | Cambridge Antibody Tech | Specific binding members,materials and methods |
FR2761689B1 (fr) | 1997-04-02 | 1999-06-25 | Transgene Sa | Fibre adenovirale modifiee et adenovirus cibles |
EP0985032B2 (en) | 1997-05-28 | 2009-06-03 | Discerna Limited | Ribosome complexes as selection particles for in vitro display and evolution of proteins |
US6673901B2 (en) | 1997-06-12 | 2004-01-06 | Research Corporation Technologies, Inc. | Artificial antibody polypeptides |
DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
US20030045681A1 (en) | 1998-05-11 | 2003-03-06 | Anthony J. Zelano | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
TWI259837B (en) | 1998-05-11 | 2006-08-11 | Eidgenossische Tech Hochscule | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
DE19932688B4 (de) | 1999-07-13 | 2009-10-08 | Scil Proteins Gmbh | Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen |
DE60121733T2 (de) | 2000-02-24 | 2007-08-09 | Philogen S.P.A. | Zusamensetzungen und Verfahren zur Behandlung von Angiogenese in pathologischen Schädigungen |
WO2001062800A1 (en) | 2000-02-24 | 2001-08-30 | Eidgenössische Technische Hochschule Zürich | Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
US6799121B2 (en) | 2000-03-30 | 2004-09-28 | York University | Sequencing of peptides by mass spectrometry |
US20110179531A1 (en) | 2000-05-09 | 2011-07-21 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
US20030073623A1 (en) | 2001-07-30 | 2003-04-17 | Drmanac Radoje T. | Novel nucleic acid sequences obtained from various cDNA libraries |
US20040043386A1 (en) | 2002-08-30 | 2004-03-04 | Todd Pray | Methods and compositions for functional ubiquitin assays |
DE10324447A1 (de) | 2003-05-28 | 2004-12-30 | Scil Proteins Gmbh | Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin |
WO2005005730A1 (en) | 2003-07-14 | 2005-01-20 | Mattex Leisure Industries | Artificial turf filament and artificial turf system |
WO2005044845A2 (en) | 2003-11-04 | 2005-05-19 | Yale University | Protein binding miniature proteins |
US7393918B2 (en) | 2003-12-11 | 2008-07-01 | Yale University | Protein binding miniature proteins and uses thereof |
DE10360483B4 (de) | 2003-12-22 | 2007-11-15 | Scil Proteins Gmbh | Expressionsvektor und dessen Verwendung |
DE102004049479A1 (de) | 2004-10-11 | 2006-04-13 | Scil Proteins Gmbh | Proteinkonjugate zur Verwendung in Therapie, Diagnose und Chromatographie |
ATE459648T1 (de) | 2005-05-11 | 2010-03-15 | Philogen Spa | Fusionsprotein von antikörper l19 gegen fibronectin ed-b und interleukin 12 |
WO2007054120A1 (de) | 2005-11-09 | 2007-05-18 | Bayer Schering Pharma Aktiengesellschaft | Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern |
EP1842553A1 (en) | 2006-04-07 | 2007-10-10 | Bayer Schering Pharma Aktiengesellschaft | Combination of an anti-EDb fibronectin domain antibody/IL2 fusion protein and a further small molecule |
BRPI0709787A2 (pt) | 2006-05-08 | 2011-03-29 | Philogen Spa | citocinas com anticorpos alvejados para terapia |
EP1892248A1 (en) | 2006-08-21 | 2008-02-27 | Eidgenössische Technische Hochschule Zürich | Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
EP1925664A1 (en) * | 2006-11-15 | 2008-05-28 | Scil proteins GmbH | Artificial binding proteins based on a modified alpha helical region of ubiquitin |
EP1955712A1 (en) | 2007-02-09 | 2008-08-13 | Scil proteins GmbH | Multimeric conjugate |
CA2778871C (en) * | 2009-12-14 | 2017-08-01 | Scil Proteins Gmbh | Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
WO2012171541A1 (en) | 2011-06-15 | 2012-12-20 | Scil Proteins Gmbh | Human fusion proteins comprising interferons and hetero-dimeric modified ubiquitin proteins |
US20150183846A1 (en) | 2012-06-13 | 2015-07-02 | Scil Proteins Gmbh | Human fusion proteins comprising single chain tnfalpha and targeting domains |
-
2012
- 2012-06-15 EP EP12729509.5A patent/EP2721152B1/en active Active
- 2012-06-15 US US14/126,358 patent/US9492572B2/en active Active
- 2012-06-15 CA CA2837804A patent/CA2837804C/en active Active
- 2012-06-15 DK DK12729509.5T patent/DK2721152T3/da active
- 2012-06-15 JP JP2014515207A patent/JP6146821B2/ja active Active
- 2012-06-15 AU AU2012268970A patent/AU2012268970B2/en not_active Ceased
- 2012-06-15 WO PCT/EP2012/061455 patent/WO2012172055A1/en active Application Filing
-
2013
- 2013-11-28 IL IL229722A patent/IL229722A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2012172055A1 (en) | 2012-12-20 |
IL229722A0 (en) | 2014-01-30 |
US20140127129A1 (en) | 2014-05-08 |
AU2012268970B2 (en) | 2016-01-28 |
IL229722A (en) | 2017-03-30 |
JP2014526881A (ja) | 2014-10-09 |
JP6146821B2 (ja) | 2017-06-14 |
CA2837804A1 (en) | 2012-12-20 |
US9492572B2 (en) | 2016-11-15 |
CA2837804C (en) | 2018-03-20 |
EP2721152B1 (en) | 2019-03-27 |
EP2721152A1 (en) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC2521568I2 (lt) | Plazmos kalikreiną surišantys baltymai | |
DK2723771T3 (da) | Serumalbuminbindende proteiner | |
DK2850103T3 (da) | ST2-antigenbindende proteiner | |
CO7020871A2 (es) | Anticuerpos anti-il-36r | |
DK2970464T3 (da) | Anti-lag-3-bindende proteiner | |
CO6811812A2 (es) | Anticuerpo anti-b7-h3 | |
DK2934584T3 (da) | Anti-gdf15-antistoffer | |
HK1202444A1 (en) | Il-1 binding proteins il-1 | |
CO6900146A2 (es) | Imidazopiridazinas sustituidas con amino | |
DK2850101T3 (da) | Anti-FcRn-antistoffer | |
DK2605335T3 (da) | Tilslutningsklemme | |
DK2606061T3 (da) | Bindingsproteiner til hepcidin | |
BR112012030311A2 (pt) | anticorpo | |
BR112013014278A2 (pt) | proteínas de ligação a tnf-a | |
CO7020862A2 (es) | Proteinas de unión al antígeno cd27l | |
BR112014004902A2 (pt) | peptídeos | |
DK2721152T3 (da) | Dimere bindingsproteiner baseret på modificerede ubiquitiner | |
CR20140127A (es) | Anticuerpo anti-abtcr | |
DK3431492T3 (da) | Humane cd30-ligandantigen-bindende proteiner | |
BR112013030352A2 (pt) | proteínas de ligação do receptor fc | |
CO6791565A2 (es) | Anticuerpos anti-notch1 | |
BR112014001120A2 (pt) | métodos de separação de polipeptídeos | |
DK2828292T3 (da) | Jcv-neutraliserende antistoffer | |
DK3521315T3 (da) | Anti-transglutaminase-2-antistoffer | |
DK2935330T3 (da) | Anti-notch3-antistoffer |